ArticleInternational journal of molecular sciences2025

Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian Carcinoma.

Serena Petrella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.